Overview
- The US Centers for Disease Control and Prevention (CDC) is expanding its Traveler-based Genomic Surveillance (TGS) program at four major US airports to test for over 30 pathogens including flu, RSV, and other respiratory viruses.
- The pilot program will enroll over 370,000 air travelers on a voluntary basis and will sample wastewater from airplanes and airport restrooms for virus testing.
- In an upgrade from only testing for COVID-19, the CDC will aim to trace the spread of variants and initiate early intervention strategies. The TGS program has previously detected new variants like the SARS-CoV-2 variant BA.2.86.
- Dr. Cindy Friedman, Chief of the CDC’s Travelers’ Health Branch, has emphasized the program's importance as an early disease detection and prevention tool, particularly as flu season sets in.
- Two private companies, Ginkgo Bioworks and XpresCheck, will implement the program, which will contribute genomic sequences of detected viruses to public databases to aid worldwide health responses.